chr22-24441268-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000675.6(ADORA2A):c.1018G>A(p.Gly340Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000675.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADORA2A | NM_000675.6 | c.1018G>A | p.Gly340Ser | missense_variant | 3/3 | ENST00000337539.12 | NP_000666.2 | |
SPECC1L-ADORA2A | NR_103546.1 | n.5197G>A | non_coding_transcript_exon_variant | 20/20 | ||||
ADORA2A-AS1 | NR_028484.3 | n.833+724C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADORA2A | ENST00000337539.12 | c.1018G>A | p.Gly340Ser | missense_variant | 3/3 | 1 | NM_000675.6 | ENSP00000336630 | P1 | |
ADORA2A-AS1 | ENST00000326341.8 | n.559+724C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000726 AC: 18AN: 248046Hom.: 0 AF XY: 0.0000595 AC XY: 8AN XY: 134510
GnomAD4 exome AF: 0.0000500 AC: 73AN: 1460750Hom.: 0 Cov.: 30 AF XY: 0.0000454 AC XY: 33AN XY: 726706
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.1018G>A (p.G340S) alteration is located in exon 3 (coding exon 2) of the ADORA2A gene. This alteration results from a G to A substitution at nucleotide position 1018, causing the glycine (G) at amino acid position 340 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at